Cite
HARVARD Citation
Capdevila, J. et al. (2017). Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC). European journal of endocrinology. 177 (4), pp. 309-317. [Online].